Ketamine was initially developed as an anesthetic, and is still used as such, especially in children and in the field by military medics. For years, IV Ketamine clinics have been treating depression and addiction across the country. Recently, the FDA approved a version of ketamine, called esketamine, as a nasal spray called Spravato, a therapy for treatment-resistant depression.
Ketamine’s success rate is nearly double that of traditional antidepressant medications. At lower doses it can feel euphoric, and at higher doses, patients can experience hallucinations and even experience dissolving of the physical environment and body, in what is often referred to as a “K-hole” phenomenon.
In the United States, the Drug Enforcement Agency has Ketamine listed as Schedule III, meaning it requires a prescription to obtain.
For more information, please visit the sites below and stay tuned for the Ketamine episodes of the Plant Medicine Podcast.
https://thethirdwave.co/psychedelics/ketamine/
https://psychedelictimes.com/ketamine/
*Please remember that this substance may be illegal where you live, especially without a prescription. We are not encouraging its use, only providing information about its most safe usage practices and principles.
Recent Ketamine-Related Articles & Podcasts
Ketamine is an anesthetic medication that is often known for its ability to induce a trance-like high, but how might ketamine work as an antidepressant?
In this episode of the Psychedelic Medicine Podcast, Steven Radowitz, MD joins to discuss the state of the research into ketamine treatments for PTSD. Dr. Steven Radowitz is the Chief Medical Officer and Co-Founder, Nushama. He believes psychedelic medicine’s framework of neuroscience, mystical experience, and integration therapy is the future of mental wellness, and current solutions often fall short, treating symptoms without addressing underlying issues. Dr. Radowitz and the Nushama team have administered thousands of ketamine journeys for mood disorders and are known to be best-in-class and among the most experienced globally.
In this episode of the Psychedelic Medicine Podcast, Nick Brüss, EdD, LMFT joins to discuss the possibilities of leveraging ketamine-assisted psychotherapy for accelerated growth. Dr. Brüss is a psychedelic therapist licensed in CA, NY and TX. He was a MAPS clinician and supervisor on the historic phase 3 MDMA for PTSD study, and is the director of psychedelic medicine advocacy for the TREAT California ballot initiative.
In this episode of the Psychedelic Medicine Podcast, Dr. Michelle Weiner joins to discuss the research on ketamine assisted psychotherapy for chronic pain conditions. Dr. Weiner is Double board-certified in Interventional Pain Medicine, Physical Medicine and Rehabilitation and the Director of Integrative Pain Management at Spine and Wellness Centers of America. She uses a unique personalized approach to treat the root cause of one's pain using a biopsychosocial model including lifestyle and plant medicine to empower her patients to cultivate health, optimize quality of life and decrease pharmaceuticals.
In this episode of the Psychedelic Medicine Podcast, Hannah Cross, LCSW joins to discuss group ketamine assisted psychotherapy for frontline healthcare workers. Hannah is a licensed clinical social worker and therapist who specializes in trauma healing and psychedelic integration, including work on LSD and psilocybin clinical trials.
In this episode of the Psychedelic Medicine Podcast, Dr. Arsalan Azam joins to discuss the potential of ketamine therapy for helping to address the stress of major life transitions. Dr. Azam is a board-certified Emergency Medicine physician and medical director of Daydream MD. He attended medical school as a Dean’s Scholar at Case Western Medical School and completed his clinical rotations at the Cleveland Clinic. He has also worked as an emergency medicine physician around the country, including as a relief physician for hospitals impacted by staffing shortages.
In this episode of the psychedelic medicine podcast, Dr. Johnathan Edwards joins to discuss the potential of ketamine treatments for mental health conditions in adolescent populations. Dr. Edwards is a board-certified anaesthesiologist and author with a key focus on treating mental health conditions with ketamine. He has provided ketamine in his practice for over 20 years and has worked with psychiatrist Dr. Sam Zand to help patients with mental health conditions.
In this episode of the Psychedelic Medicine Podcast, Dr. Steven Mandel returns to discuss ketamine treatments for alcohol use disorder. Dr. Mandel is an internationally recognized expert and pioneer in the use of ketamine-infusion therapy to treat mental health disorders and chronic pain. He is a board-certified anesthesiologist with a masters in psychology and over 40 years of experience working with ketamine. He is the founder and president of Ketamine Clinics Los Angeles and also the Founder and first president of American Society of Ketamine Physicians, Psychotherapists & Practitioners (ASKP3).
In this episode of the Plant Medicine Podcast, Dr. Mark Braunstein returns to discuss potential concerns surrounding the use of ketamine, especially use which is not overseen by a knowledgeable medical professional. Dr. Braunstein is a whole-health psychiatrist with 22 years of clinical experience. He is the medical director for multiple mental health and psychedelic psychotherapy clinics in Colorado, New Mexico, and Utah and he also runs in-patient and out-patient programs for addiction. Additionally, Dr. Braunstein is involved in multiple projects focused on expanding access, awareness, research, and safety in the field of psychedelics.
This first episode of the Plant Medicine Podcast in 2021 features a conversation with Dr. Reid Robison, discussing the potentials of using psychedelics to treat eating disorders. Dr. Robison is a board-certified psychiatrist and the chief medical officer at Novamind. He is also the co-founder of Cedar Psychiatry, founder of the Polizzi Free Clinic, and adjunct faculty at the University of Utah. Dr. Robison serves as the medical director of Center for Change—a top eating disorder treatment center—and he is currently the coordinating investigator for the upcoming MAPS study looking at the potential for MDMA-assisted psychotherapy as a treatment for eating disorders.
Dr. Adolph shares the brief history of how ketamine was originally created, how it came to be used in the mental health arena, and its effectiveness for those with depression. He covers what the research has shown, as well as what he’s seen in his clinic and in his own personal journey with the medicine.